Self expandable stent (SEMS) constitutes the main palliative treatment in advanced esophageal cancer. The palliative effect of SEMS is immediate when it comes to relief of dysphagia. The duration of this effect is however questionable. The design of SEMS can be of importance since the device can dislodge and as a consequence of that dysphagia recur. The hypothesis has therefore been formulated that a partially covered SEMS is associated with less tendency to dislocate as compared to those SEMS, recently developed, which are covered through their entire length.

Inclusion Criteria:

• Verified Squamous Cell Carcinoma or Adenocarcinoma of esophagus or Gastro Esophageal Junction (GEJ)
• Age above 18 years.
• Dysphagia scoring grade two or worse
• Not amenable for curative treatment
• Informed consent to participate

Exclusion Criteria:

• Concomitant cancer disease
• Inability to comply with study protocol
• Previous stent treatment
• Proximal location of the tumour in the esophagus.
• Need for more than one stent deployment.